Wazni O, Dandamudi G, Sood N, et al. Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy. Heart rhythm. 2022;19(2):197–205.

Article  PubMed  Google Scholar 

Packer D, Mark D, Robb R, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirchhof P, Camm A, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305–16.

Article  PubMed  Google Scholar 

Wazni O, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021;384(4):316–24.

Article  CAS  PubMed  Google Scholar 

Andrade J, Wells G, Deyell M, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384(4):305–15.

Article  CAS  PubMed  Google Scholar 

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.

Article  PubMed  Google Scholar 

Valderrábano M, Peterson L, Swarup V, et al. Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020;324(16):1620–8.

Article  PubMed  Google Scholar 

Haldar S, Khan H, Boyalla V, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41(47):4471–80.

Article  PubMed  PubMed Central  Google Scholar 

Kaitani K, Inoue K, Kobori A, et al. Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial. Eur Heart J. 2016;37(7):610–8.

Article  CAS  PubMed  Google Scholar 

Arbelo E, Brugada J, Blomström-Lundqvist C, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38(17):1303–16.

PubMed  Google Scholar 

Duytschaever M, Demolder A, Phlips T, et al. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial. Eur Heart J. 2018;39(16):1429–37.

Article  CAS  PubMed  Google Scholar 

Schleberger R, Metzner A, Kuck KH, et al. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry. Pharmacol Res Perspect. 2021;9(6):e00880.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao S, Dai W, Zhang L, et al. Risk of cardiovascular events, stroke, congestive heart failure, interstitial lung disease, and acute liver injury: dronedarone versus amiodarone and other antiarrhythmics. J Atrial Fibrillation. 2013;6(4):890.

Google Scholar 

Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007;357(10):987–99.

Article  CAS  PubMed  Google Scholar 

Boriani G, Blomström-Lundqvist C, Hohnloser SH, et al. Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation. Europace. 2019;21(12):1764–75.

PubMed  Google Scholar 

Popa MA, Kottmaier M, Risse E, et al. Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence? Clin Res Cardiol. 2022;111(1):85–95.

Article  PubMed  Google Scholar 

Vanam S, Darden D, Munir MB, et al. Characteristics and outcomes of recurrent atrial fibrillation after prior failed pulmonary vein isolation. J Interv Card Electrophysiol. 2022;64(3):715–22.

Article  PubMed  PubMed Central  Google Scholar 

Spitzer SG, Károlyi L, Rämmler C, et al. Treatment of recurrent nonparoxysmal atrial fibrillation using focal impulse and rotor mapping (FIRM)-guided rotor ablation: early recurrence and long-term outcomes. J Cardiovasc Electrophysiol. 2017;28(1):31–8.

Article  PubMed  Google Scholar 

Haïssaguerre M, Hocini M, Sanders P, et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16(11):1138–47.

Article  PubMed  Google Scholar 

Wasmer K, Dechering D, Köbe J, et al. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation. Clin Res Cardiol. 2016;105(9):738–43.

Article  PubMed  Google Scholar 

Li Z, Wang S, Hidru TH, et al. Long atrial fibrillation duration and early recurrence are rreliable predictors of late recurrence after radiofrequency catheter ablation. Front Cardiovasc Med. 2022;9:864417.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai L, Yin Y, Ling Z, et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol. 2013;164(1):82–7.

Article  PubMed  Google Scholar 

Mesquita J, Cavaco D, Ferreira AM, et al. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy. J Interv Card Electrophysiol. 2018;52(1):39–45.

Article  PubMed  Google Scholar 

Touboul P, Brugada J, Capucci A, et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J. 2003;24(16):1481–7.

Article  CAS  PubMed  Google Scholar 

Vaduganathan M, Piccini JP, Camm AJ, et al. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial. Eur J Heart Fail. 2022;24(6):1094–101.

Article  CAS  PubMed  Google Scholar